Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management
Recruiting · NCT07091487 · Interventional (participants receive a specific treatment) · Lead sponsor: Katherine Vickery
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to learn if the Diabetes Homelessness Medication Support (D-HOMES) wellness coaching model is effective for adults who speak English or Spanish, have Type 2 diabetes with an HbA1c at or above 7.5, and have recently experienced homelessness. Researchers will compare a one-time education session about diabetes to 10 wellness coaching sessions to see if there are differences between the groups' health outcomes. The main questions it aims to answer are: * Do D-HOMES participants have greater reductions in HbA1c at 3 months than participants who received education? * Do D-HOMES participants have greater reductions in HbA1c at 6 and 12 months compared to those who received education? * Do D-HOMES participants have improvements in blood pressure control, quality of life, self-reported psychological wellness, diabetes distress, and diabetes medication adherence and self-management at 3, 6, and 12 months? * What factors must be considered to make D-HOMES scalable? Participants will: * complete 5 assessments including two baseline assessments and follow-ups at months 3,6, and 12 * participate in a one-time education session or 10 weeks of wellness coaching.
Who can take part
Inclusion criteria
- Age 18 yrs. or older
- English or Spanish-speaking
- Recent homelessness by HUD and HHS definitions
- Any housing instability in the last 12 mo. (includes supported housing or worry about paying rent)
- Significant housing instability in the last 24 mos. (includes any stay in shelter, outside, or places not meant for human habitation)
- Self-reported diagnosis of type 2 diabetes with A1c \>7.5%, later verified in medical record and study lab. test
- Plan to stay in local area or be reachable by phone for the next 12 months
- Willingness to work on medication adherence and diabetes self-care
Exclusion criteria
- Inability to provide informed consent (e.g., presence of a legal guardian, prisoners)
- Active psychosis or intoxication precluding ability to give informed consent
- Pregnant or lactating people at initial enrollment, determined by specific screening questions.
Where it is running
1 location listed across 1 US state.
- Hennepin Healthcare Research Institute - Minneapolis, Minnesota, United States